{
    "nctId": "NCT01596439",
    "briefTitle": "A Prospective Study to Evaluate the Effect of Systemic Adjuvant Therapy on the Cognitive Function of Breast Cancer Patients",
    "officialTitle": "N/A",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Examine the variation of cognitive function at various time-points in stage I-III breast cancer patients who have undergone or are undergoing adjuvant systemic therapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Histologically confirmed stage I-III breast carcinoma\n2. \\< 65 years old\n3. Female\n\nExclusion Criteria:\n\n1. Previous exposure to chemotherapy/anti-hormonal therapy for any other malignancy\n2. Previous neoadjuvant therapy for breast cancer\n3. Concomitant second primary in-situ or invasive carcinoma or previous history of carcinoma/carcinoma-in-situ\n4. Known disease or injury to the central nervous system (including neurodegenerative diseases, epilepsy), severe visual or auditory disorders\n5. Motor weakness due to any cause which makes using a touchscreen computer difficult\n6. Known background of depression, anxiety disorders or other neurobehavioural conditions\n7. Ongoing use of tranquilisers or anti-depressants\n8. Previous neuropsychological testing\n9. Current or previous history of alcohol or drug dependent",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT"
}